hepatitis C

Pharmasset Poised to Pay 20% on Gilead Closing in First Quarter: Real M&A
Bloomberg
Mon, 12/5/11 - 10:14 pm
Pharmasset
Gilead
M&A
PSI-7977
hepatitis C
Drugmakers target hepatitis C
Yahoo/Investor's Business Daily
Sat, 12/3/11 - 03:57 pm
Tibotec
Bristol-Myers Squibb
JNJ
hepatitis C
TMC435
declatasvir. Ribavirin
interferon
Idenix Pharmaceuticals Shares Surged: What You Need to Know
Motley Fool
Sat, 12/3/11 - 03:54 pm
Idenix
IDX184
hepatitis C
Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Yahoo/AP
Fri, 12/2/11 - 12:04 pm
Bristol-Myers Squibb
JNJ
hepatitis C
daclatasvir
TMC435
Inhibitex Shares Popped: What You Need to Know
Motley Fool
Fri, 12/2/11 - 11:21 am
Inhibitex
hepatitis C
Inhibitex rallies after reporting data from Hepatitis C Phase 1b trial
Yahoo/Fly on the Wall
Tue, 11/29/11 - 10:20 am
Inhibitex
hepatitis C
INX-189
Gilead's Pharmasset Purchase Could Help Double Market Cap By 2020
Seeking Alpha
Mon, 11/28/11 - 11:38 am
Gilead
Pharmasset
M&A
hepatitis C
GSK
JNJ
Bristol-Myers Squibb
PSI-7977
Vertex
HIV
Gilead to Buy Pharmasset for $11B for Hepatitis C Treatments
Bloomberg
Mon, 11/21/11 - 09:44 am
Gilead
Pharmasset
hepatitis C
Achillion in Talks With Potential Buyers or Partners, Chief Executive Says
Bloomberg
Sat, 11/19/11 - 11:35 am
Achillion
hepatitis C
GSK
Novartis
Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate
Bloomberg
Mon, 11/7/11 - 11:02 am
Pharmasset
hepatitis C
PSI-7977
Dendreon, Merck's Hepatitis C Drug: Future Prospects Look Encouraging
Seeking Alpha
Mon, 11/7/11 - 09:25 am
Merck
Dendreon
hepatitis C
Victrelis
Inhibitex Investors: Why Shares Popped 115%
Motley Fool
Sun, 11/6/11 - 11:57 am
Inhibitex
INX-189
hepatitis C
Positive Interim Data From a Phase 2 Study of INCIVEK™ (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting®
Yahoo/BusinessWire
Sat, 11/5/11 - 02:47 pm
Incivek
Vertex Pharmaceuticals
hepatitis C
HIV
Inhibitex Soars as Investors See Another Pharmasset in the Making
TheStreet.com
Fri, 11/4/11 - 09:29 am
Inhibitex
Pharmasset
INX-189
hepatitis C
PSI-7977
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Pharmasset
hepatitis C
Ribavirin
Vertex
Abbott Laboratories
PSI-7977
JNJ
Roche
Bristol-Myers Squibb
Vertex Bests Merck in New Hepatitis C Drug Sales
NY Times, NY
Sat, 10/29/11 - 12:55 pm
hepatitis C
Merck
Vertex
Incivek
Victrelis
[video] The Next Big Thing in Biotech: Pharmasset
TheStreet.com
Fri, 10/28/11 - 11:25 am
hepatitis C
Pharmasset
PSI-7977
Vertex A Steal Based On Blockbuster Hepatitis C Drug Sales
Seeking Alpha
Fri, 10/28/11 - 09:34 am
Vertex
earnings
hepatitis C
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
SciClone
Pharmasset
Vertex tests shorter Incivek therapy in patient subset
Fierce Pharma
Mon, 10/24/11 - 12:02 pm
Vertex
Incivek
hepatitis C
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Roche
Anadys
hepatitis C
ANA773
Abbott Laboratories

Pages